IOIrina G. Ovchinnikova

Irina G. Ovchinnikova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Irina G. Ovchinnikova has a total of 157 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Novel (Azolo)Pyrimidine Derivatives as Dual Modulators of NO and IL‐6 in Murine Macrophages and Human Monocytes

    by Irina G. Ovchinnikova, Olga V. Fedorova, Nikolay A. Rasputin, Grigory A. Kim, Elena S. Filatova, Polina K. Titova, Denis A. Babkov, Elena V. Sokolova, Andrey V. Lukyanov, Roman D. Danilov, et al.

    Small molecules that simultaneously suppress nitric oxide (NO) and interleukin‑6 (IL‑6) offer a strategy to alleviate pathological inflammation. Building on our previous work with aryl‑substituted azaheterocycles, we synthesized 33 new pyrimidine and azolopyrimidine derivatives bearing amino, amide, hydroxyl, or halide groups to enhance hydrogen‑bonding capacity and improve inhibitory activity against both mediators. Screening in C57BL/6J mouse peritoneal macrophages identified nine compounds that markedly inhibited NO production at 50 µM. Two leads—triazolo[1,5‑a]pyrimidine 12bc and dihydropyrimidine carboxamide 7a—emerged as potent dual inhibitors. Compound 7a showed IC 50 values of 0.47 µM (NO) and 0.1 µM (IL‑6); 12bc gave 8.66 µM (NO) and 0.85 µM (IL‑6), both with acceptable cytotoxicity. In human PBMC‑derived monocytes, both compounds dose‑dependently suppressed LPS‑induced IL‑6 secretion; 12bc was slightly more potent, reducing IL‑6 to near‑baseline at 100 µM, comparable to dexamethasone. In an LPS/ATP pyroptosis model, they protected monocytes from inflammatory death, with 12bc nearly restoring normal cell morphology. Docking studies into mouse iNOS and IL‑6 suggested plausible binding modes and structure–activity relationships. These (azolo)pyrimidine scaffolds represent promising leads for safe, dual‑acting anti‑inflammatory agents.

  • Green Method for the Synthesis of Promising Tuberculostatic Agents—N-Acylhydrazono Podands—in Water

    by Olga V. Fedorova, Irina G. Ovchinnikova, Pavel A. Slepukhin, Gennady L. Rusinov

    A reproducible and scalable method for the synthesis of promising tuberculostatic agents—N-acylhydrazono podands—in water without the use of catalysts has been developed. The effect of the molar ratios of the starting reagents and the solvent (ethanol or water), as well as the duration of ultrasonic irradiation, on the yield of the target product was studied. The increased selectivity of the condensation reaction of formyl podands with isoniazid in water under ultrasonic irradiation provides an almost quantitative yield of the target products without additional purification. The method can be recommended for the synthesis of a wide range of pharmacologically significant substituted hydrazones.

  • Modern Strategies of Drug Therapy: Multi-Target Drug Delivery, Bioimaging, Diagnostics

    by O. V. Fedorova, I. G. Ovchinnikova, G. L. Rusinov, V. V. Avdeeva, A. P. Zhdanov, K. Yu. Zhizhin, N. T. Kuznetsov, L. Ya. Zakharova, D. A. Kuznetsova, Yu. S. Razuvaeva, et al.


  • Open Access

    Antituberculosis activity of some 3,6-disubstituted 1,2,4,5-tetrazines

    by Rashida I. Ishmetova, Ilya N. Ganebnykh, Nina K. Ignatenko, Irina G. Ovchinnikova, Olga V. Fedorova, Sergei N. Skornyakov, Gennady L. Rusinov

    The increase in the incidence of tuberculosis, especially in the post-Covid period, associated with the presence of latent infections and multiple drug resistance, dictates the need to develop new antimicrobial drugs. Here we wish to report the synthesis of 3,6-disubstituted 1,2,4,5-tetrazine derivatives containing N-, O- and C-nucleophile residues, as well as pharmacophoric hydrazone and oligooxyethylene fragments, and their screening against the pathogen Mycobacterium tuberculosis. Substances with pronounced antimycobacterial activity in vitro were identified (MIC = 0.18–3.12 μg/ml). An acute toxicity in vivo and membranotropic properties towards biometals have been studied for the most active compounds.


  • Asymmetric Synthesis of Dihydropyrimidinethione Podand in the Presence of C2‐Symmetric Bis(Hydroxy)Proline‐Containing Amides

    by Elena S. Filatova, Olga V. Fedorova, Irina G. Ovchinnikova, Sergei V. Kochetkov, Konstantin A. Chistiakov, Gennady L. Rusinov

    A stereoselective Biginelli reaction involving a CH‐active podand, thiourea, and benzaldehyde was carried out using C2‐symmetric bis(hydroxy)proline‐containing amides as chiral inducers. The target dihydropyrimidinethione‐containing podand was obtained with an enantiomeric excess of 65–75 % and a yield of 58 % under mild conditions. It was established that in the process of asymmetric induction the value of ee depended on the presence of OH group in the proline fragment and of the linker structure in the chiral inducer molecule, in particular, on the presence of asymmetric carbon atoms and the movability of the single bond between them in the linker itself. Based on experimental data, one of the probable reaction mechanisms confirming the special role of the L ‐proline or trans ‐4‐hydroxyproline fragments in asymmetric induction has been proposed. The developed technique for obtaining an active tuberculostatic agent expands the possibilities for using C2‐symmetric chiral inducers in asymmetric catalysis and is of interest for the synthesis of enantiomerically pure compounds of similar structure.


  • Open Access

    Novel Substituted Azoloazines with Anticoagulant Activity

    by Alexander A. Spasov, Olga V. Fedorova, Nikolay A. Rasputin, Irina G. Ovchinnikova, Rashida I. Ishmetova, Nina K. Ignatenko, Evgeny B. Gorbunov, Gusein A. O. Sadykhov, Aida F. Kucheryavenko, Kseniia A. Gaidukova, et al.

    Hypercytokinemia, or cytokine storm, often complicates the treatment of viral and bacterial infections, including COVID-19, leading to the risk of thrombosis. However, the use of currently available direct anticoagulants for the treatment of COVID-19 patients is limited due to safety reasons. Therefore, the development of new anticoagulants remains an urgent task for organic and medicinal chemistry. At the same time, new drugs that combine anticoagulant properties with antiviral or antidiabetic activity could be helpfull in the treatment of COVID-19 patients, especially those suffering from such concomitant diseases as arterial hypertension or diabetes. We have synthesized a number of novel substituted azoloazines, some of which have previously been identified as compounds with pronounced antiviral, antibacterial, antidiabetic, antiaggregant, and anticoagulant activity. Two compounds from the family of 1,2,4-triazolo[1,5-a]pyrimidines have demonstrated anticoagulant activity at a level exceeding or at least comparable with that of dabigatran etexilate as the reference compound. 7,5-Di(2-thienyl)-4,5-dihydro-[1,2,4]triazolo[1,5-a]pyrimidine has shown the highest ability to prolong the thrombin time, surpassing this reference drug by 2.2 times. This compound has also exhibited anticoagulant activity associated with the inhibition of thrombin (factor IIa). Moreover, the anticoagulant effect of this substance becomes enhanced under the conditions of a systemic inflammatory reaction.


  • Nanosized metal or silicon oxides and L‐proline or 4‐hydroxy‐L‐proline in stereoselective synthesis of a dihydropyrimidinethione podand

    by Elena S. Filatova, Olga V. Fedorova, Irina G. Ovchinnikova, Konstantin A. Chistyakov, Ilya N. Ganebnykh, Mikhail A. Uimin, Gennady L. Rusinov

    The stereoselective Biginelli reaction involving a CH‐active podand, thiourea, and benzaldehyde using nanosized metal oxides (NiO, Fe3O4, CuO, Al2O3, SiO2, and TiO2‐SiO2), Brönsted acid, and commercially available chiral inductors (L‐proline or 4‐hydroxy‐L‐proline) was studied. The target dihydropyrimidinethione‐containing podand was obtained with an enantiomeric excess of 70% and a moderate yield under mild conditions in the presence of nanooxide NiO and 4‐hydroxy‐L‐proline. The adsorption of initial reactants and chiral inductor on the surface of nickel nanooxide was studied by IR spectroscopy. The activating and coordinating effect of the nanosized metal oxide on the initial reagents leading to an increasing the chemoselectivity and stereoselectivity of the Biginelli reaction was shown. On the basis of experimental data, one of the probable reaction mechanisms was proposed. This work further expanded the use of nanosized metal oxides in asymmetric catalysis and presented a new method for obtaining a valuable optically active podand with a 3,4‐dihydropyrimidine‐2‐(1H)‐thione moiety. Thus, the obtained results can be of interest for medicinal chemistry in the asymmetric one‐step synthesis of other enantiomerically pure compounds.


  • Open Access

    Amino Derivatives of Diaryl Pyrimidines and Azolopyrimidines as Protective Agents against LPS-Induced Acute Lung Injury

    by Alexander Spasov, Irina Ovchinnikova, Olga Fedorova, Yulia Titova, Denis Babkov, Vadim Kosolapov, Alexander Borisov, Elena Sokolova, Vladlen Klochkov, Maria Skripka, et al.

    The problem of lung damage originating from excessive inflammation and cytokine release during various types of infections remains relevant and stimulates the search for highly effective and safe drugs. The biological activity of the latter may be associated with the regulation of hyperactivation of certain immune cells and enzymes. Here, we propose the design and synthesis of amino derivatives of 4,6- and 5,7-diaryl substituted pyrimidines and [1,2,4]triazolo[1,5-a]pyrimidines as promising double-acting pharmacophores inhibiting IL-6 and NO. The anti-inflammatory activity of 14 target compounds was studied on isolated primary murine macrophages after LPS stimulation. Seven compounds were identified to inhibit the synthesis of nitric oxide and interleukin 6 at a concentration of 100 µM. The most active compounds are micromolar inhibitors of IL-6 secretion and NO synthesis, showing a minimal impact on innate immunity, unlike the reference drug dexamethasone, along with acceptable cytotoxicity. Evaluation in an animal model of acute lung injury proved the protective activity of compound 6e, which was supported by biochemical, cytological and morphological markers.


  • Pericyclic reactions in the synthesis of new 5-aryl-5,6-dihydroquinolino[2,1-b]quinazolin-12-ones

    by Irina G. Ovchinnikova, Grigory A. Kim, Eugeniya G. Matochkina, Mikhail I. Kodess, Emiliya V. Nosova, Gennady L. Rusinov, Valery N. Charushin

    Novel tetracyclic 5-aryl-5,6-dihydroquinolino[2,1-b]quinazolin-12-ones bearing benzo-15-crown-5 ether and dimethoxyphenyl moieties were prepared by one-pot cascade synthesis involving the thermally allowed pericyclic transformations of (E)-2-(2-methoxystyryl)quinazolinones. The pseudocyclic transition state of six-electron electrocyclization has been located and the activation barrier has been estimated by RHF/3-21G and 6-311G* calculation methods. The crystal structure of N-[4-(2,3-dimethoxy-12-oxo-5,6-dihydroquinolino[2,1-b]quinazolin-5-yl)-3-methoxyphenyl]acetamide was determined by X-ray diffraction analysis.

  • Open Access

    (E)-2-(Hydroxystyryl)-3-phenylquinazolin-4(3H)-ones: synthesis, photochemical and luminescent properties

    by Grigory A. Kim, Irina G. Ovchinnikova, Emiliya V. Nosova, Gennady L. Rusinov, Valery N. Charushin